Verition Fund Management’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Verition Fund Management’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,414	Closed	-$98.3K	–	3046
2023 Q4	$98.3K	Sell	18,414 -145	-0.8%	-$894	﹤0.01%	2145
2023 Q3	$148K	Sell	18,559 -21,105	-53%	-$125K	﹤0.01%	2053
2023 Q2	$169K	Buy	+39,664	New	+$225K	﹤0.01%	1896
2022 Q4	–	Sell	-832	Closed	-$27K	–	2942
2022 Q3	$27K	Hold	832	–	–	﹤0.01%	2760
2022 Q2	$33K	Buy	+832	New	+$60.8K	﹤0.01%	2185

Verition Fund Management's SNCE Position: Q1 2024 in Review

Verition Fund Management sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 18,414 shares — an estimated $98.3K sold.

Verition Fund Management first reported a position in SNCE in Q2 2022 and held it in 5 quarters. The position peaked at $169K in Q2 2023. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Verition Fund Management reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Verition Fund Management sold 18,414 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $98.3K.
Verition Fund Management first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Verition Fund Management's Science 37 Holdings, Inc. Common Stock position peaked at $169K in Q2 2023.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.